Projects per year
Personal profile
Education/Academic qualification
PhD, Identification of SMYD2 interactions and Substrates by Immunoprecipitation Coupled to MS, University of Ottawa
1 Sep 2005 → 1 May 2009
Award Date: 1 May 2009
| Supervised by |
|
|---|
Master, Regulation of Erythroid-Specific 5-Aminolevulinate Synthase (ALAS2) by Hypoxia, Carleton University - Canada's Capital University
1 Sep 2003 → 2 May 2005
Award Date: 2 May 2005
| Supervised by |
|
|---|
Bachelor, Hydroxilation And Protein Stability Under Hypoxia, Carleton University - Canada's Capital University
1 Sep 1998 → 1 May 2003
Award Date: 1 May 2003
| Supervised by |
|
|---|
External positions
Dasman Diabetes Institute
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Improving glucose control of poorly controlled insulin treated T2DM patients in Kuwait
Al-Mulla, F. (PI), Abdulghani, M. (PI), Alajmi, F. (CoI), Abu-Farha, M. (CoI), AlEssa, T. (CoI), Al-Otaibi, N. (CoI), Shehab, M. (CoI) & Ahmed, M. (CoI)
1/05/24 → 1/05/29
Project: Dasman Diabetes Institute Projects
-
The Impact of GLP-1/GIP Dual Agonists in Addition to Pioglitazone on Adipose Tissue Metabolism and Their Role in Modulating Insulin Sensitivity and Beta Cell Function in Type 2 Diabetes Mellitus
Abu-Farha, M. (PI), Abdul-Ghani, M. (CoI), Abubaker, J. (CoI), Al-Khairi, I. (CoI), AlSabbagh, A. (CoI), Cherian, P. (CoI), Malik, M. (CoI), Qaddoumi, M. (CoI) & Thangavel, A. (CoI)
1/04/24 → 1/04/29
Project: Dasman Diabetes Institute Projects
-
Functional and Pharmacogenomic Characterization of Hallmark Genetic Risk variants for Metabolic Traits in The Kuwaiti Population: Enrichening KADEM and The Kuwait Variome Database
Thangavel, A. (PI), Al-Mulla, F. (PI), Abu-Farha, M. (CoI), Abubaker, J. (CoI), Dashti, M. (CoI), Malik, M. (CoI), Mohammed, A. (CoI), Iqbal, R. (CoI), Sriraman, D. (CoI), Melhem, M. (CoI), Mohamed Channanath, A. (CoI), Elsa John, S. (CoI), Jacob, S. (CoI), Al-Madhoon, A. (CoI) & Haddad, D. (CoI)
1/02/24 → 1/02/29
Project: Dasman Diabetes Institute Projects
-
Kuwait Diabetes Epidemiological Study Diabetes high risk Follow up study (KADEM)
Abu-Farha, M. (PI), Al-Mulla, F. (PI), Bennakhi, A. (PI), Abubaker, J. (PI), Abdulghani, M. (CoI), Al Ozairi, E. (CoI), Mohammed, A. (CoI), Sladek, R. (CoI), Sriraman, D. (CoI), Alkandari, A. (CoI), Ahmad, R. (CoI), Eaaswarkhanth, M. (CoI), Al-Madhoon, A. (CoI), Sindhu, S. (CoI), Al-Sharrah, S. (CoI), Arefanian, H. (CoI), Alterki, A. (CoI), Attar, A. A. (CoI), Hasan, A. (CoI), Haidar, A. (CoI), Saad, F. (CoI), Qaddoumi, M. G. (CoI), Alanbaei, M. (CoI), Al-Rashed, F. (CoI), Coffee, N. T. (CoI), Al-Ali, W. (CoI), Daniel, M. (CoI), Mathur, A. (CoI), Akther, N. (CoI), Akhter, N. (CoI), Thomas, R. (CoI), Kochumon, S. (CoI), Laiaqat, A. (CoI), Chandy, B. S. (CoI), Osman, M. (CoI), Melhem, M. (CoI), Al-Sultan, M. (CoI), Jose, R. M. (CoI), Warsam, S. (CoI), Joseph, S. (CoI), Atizado, V. L. (CoI), Vijayan, V. (CoI), Jalali, M. (CoI), Bennakhi, A. (CoI), Kavalakatt, S. (CoI) & Khadir, A. (CoI)
1/02/21 → 1/03/30
Project: Dasman Diabetes Institute Projects
-
Phase 2: Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
Al-Mulla, F. (PI), Abdul-Ghani, M. (PI), Abu-Farha, M. (CoI), Al-Ajmi, F. (CoI), AlEssa, T. (CoI), Khalifa, D. (CoI), Abubaker, J. (CoI) & Devarajan, S. (CoI)
1/03/24 → 1/06/26
Project: Dasman Diabetes Institute Projects
-
Poursharifi, P., Schmitt, C., Chenier, I., Leung, Y. H., Oppong, A. K., Bai, Y., Klein, L. L., Vilanou, L., Al-Mass, A., Lussier, R., Abu-Farha, M., Abubaker, J., Al-Mulla, F., Dumais, Flamand, N., Provost, N., Bernard, C., Delerive, P., Peyot, M. L., ... Prentki, M. (2026). ABHD6 suppression attenuates pro-inflammatory responses in mice and promotes anti-inflammatory polarization of macrophages during endotoxin stress. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1871(1), Article 159694. https://doi.org/10.1016/j.bbalip.2025.159694Open Access1 Scopus citations
-
Alterki, A., AlShawaf, E., Alawadh, M., Shamiyah, D., Alkhairi, I., Cherian, P., Sriraman, D., Ebrahim, M., Alterki, M., Bin-Hasan, S., Al-Mulla, F., Abu-Farha, M., & Abubaker, J. (2026). Circulating IGFBP-7 in Obstructive Sleep Apnea: A Single-Cohort Preliminary Assessment of Its Diagnostic Performance and Post-Treatment Dynamics. Biomedicines, 14(8), Article 1780. https://doi.org/10.3390/biomedicines14081780Open Access
-
Abu-Farha, M., Boulton, A. J. M., Frykberg, R. G., Malik, R. A., Alajmi, F., Abubaker, J., Alarouj, M., Bennakhi, A., & Al-Mulla, F. (2026). Diabetic foot ulcer prevention in Kuwait. The Lancet Diabetes and Endocrinology, 14(8), 627. https://doi.org/10.1016/S2213-8587(26)00131-2
-
Al-Ajmi, F., Abu-Farha, M., Albatineh, A. N., Ali, Z., AL-Enezi, A., Alterki, M., Alhammad, R., AlHarbi, R., Shehab, M., Abdul-Ghani, M., Abubaker, J., & Al-Mulla, F. (2025). Association of wrist circumference with metabolic dysfunction associated fatty liver disease in the KADEM cohort. Frontiers in Endocrinology, 16, Article 1580209. https://doi.org/10.3389/fendo.2025.1580209Open Access
-
Yousef, R., Alkazemi, D. U. Z., Abu-Farha, M., Abubaker, J., Devarajan, S., Rahman, A., & Al-Mulla, F. (2025). Associations of TAS1R2 and TAS2R38 Genetic Variants with Sugar-Sweetened Beverage Intake and Obesity Risk in Kuwaiti Adolescents: A Cross-Sectional Study. Children, 12(9), Article 1192. https://doi.org/10.3390/children12091192Open Access1 Scopus citations